PAVmed (PAVM) Other Accumulated Expenses (2016 - 2024)
PAVmed (PAVM) posted quarterly Other Accumulated Expenses of $652000.0 for Q4 2024, up 183.48% quarter-over-quarter from $230000.0 in Q2 2020.
PAVmed (PAVM) Other Accumulated Expenses (2016 - 2024) Analysis & Trends
PAVmed's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $652000.0 for Q4 2024.
- In Q4 2024, Other Accumulated Expenses changed N/A year-over-year to $652000.0; the TTM figure through Dec 2024 stood at $652000.0 (changed N/A YoY), while the FY2024 annual figure was $652000.0, changed N/A from the prior year.
- Other Accumulated Expenses for Q4 2024 stood at $652000.0, up from $230000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $652000.0 in Q4 2024, with the low at $160000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 652,000.00 |
| Jun 30, 2020 | 230,000.00 |
| Mar 31, 2020 | 160,000.00 |
| Dec 31, 2019 | 88,000.00 |
| Jun 30, 2019 | 191,933.00 |
| Mar 31, 2019 | 41,090.00 |
| Dec 31, 2018 | 49,872.00 |
| Sep 30, 2018 | 55,311.00 |
| Jun 30, 2018 | 94,247.00 |
| Mar 31, 2018 | 3,108.00 |
| Dec 31, 2017 | 11,203.00 |
| Sep 30, 2017 | 51,750.00 |
| Jun 30, 2017 | 69,000.00 |
| Dec 31, 2016 | 28,000.00 |